From: Health-related quality of life following minimally invasive totally endoscopic mitral valve surgery
Item | EA group | SA group | P |
---|---|---|---|
Male/Female | 43/35 | 55/30 | 0.21 |
Age (years) | 51.49 ± 11.87 | 51.69 ± 11.69 | 0.91 |
Current NYHA (median) | II | II | |
BMI (kg/m2) | 22.66 ± 1.59 | 22.50 ± 1.80 | 0.55 |
Lesion types of mitral valve | |||
Mitral stenosis | 26 | 21 | 0.23 |
Mitral insufficiency | 38 | 40 | |
Mitral stenosis and insufficiency | 14 | 24 | |
LVED | 58.35 ± 8.32 | 57.72 ± 8.69 | 0.64 |
LVEF (%) | 58.50 ± 6.94 | 57.42 ± 5.79 | 0.29 |
Surgery strategy | |||
Mitral valve repair | 8 | 17 | 0.13 |
Mitral valve replacement | 70 | 68 | |
bioprothetic valves | 39 | 28 | 0.04 |
Preservation of Subvalvular Apparatus | 33 | 54 | 0.01 |
tricuspid valve plasty | 15 | 27 | 0.10 |